These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning. Nasehi M; Zamanparvar M; Ebrahimi-Ghiri M; Zarrindast MR Behav Brain Res; 2016 Mar; 300():114-22. PubMed ID: 26698395 [TBL] [Abstract][Full Text] [Related]
5. Inbred mouse strain differences in the establishment of long-term fear memory. Balogh SA; Wehner JM Behav Brain Res; 2003 Mar; 140(1-2):97-106. PubMed ID: 12644283 [TBL] [Abstract][Full Text] [Related]
6. Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences. Kuehl LK; Deuter CE; Hellmann-Regen J; Kaczmarczyk M; Otte C; Wingenfeld K Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109751. PubMed ID: 31446157 [TBL] [Abstract][Full Text] [Related]
7. Representational similarity analysis offers a preview of the noradrenergic modulation of long-term fear memory at the time of encoding. Visser RM; Kunze AE; Westhoff B; Scholte HS; Kindt M Psychoneuroendocrinology; 2015 May; 55():8-20. PubMed ID: 25705798 [TBL] [Abstract][Full Text] [Related]
8. C57BL/6J and DBA/2J mice differ in extinction and renewal of extinguished conditioned fear. Waddell J; Dunnett C; Falls WA Behav Brain Res; 2004 Oct; 154(2):567-76. PubMed ID: 15313046 [TBL] [Abstract][Full Text] [Related]
9. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Lähdesmäki J; Sallinen J; MacDonald E; Scheinin M Neuropsychopharmacology; 2004 Jul; 29(7):1282-93. PubMed ID: 15039766 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity to trauma-associated cues is restricted to vulnerable traumatized rats and reinstated after extinction by yohimbine. Le Dorze C; Gisquet-Verrier P Behav Brain Res; 2016 Oct; 313():120-134. PubMed ID: 27392642 [TBL] [Abstract][Full Text] [Related]
11. Fear-potentiated startle response in mice: genetic analysis of the C57BL/6J and DBA/2J intercross. McCaughran JA; Bell J; Hitzemann RJ Pharmacol Biochem Behav; 2000 Feb; 65(2):301-12. PubMed ID: 10672983 [TBL] [Abstract][Full Text] [Related]
12. Beyond extinction: erasing human fear responses and preventing the return of fear. Kindt M; Soeter M; Vervliet B Nat Neurosci; 2009 Mar; 12(3):256-8. PubMed ID: 19219038 [TBL] [Abstract][Full Text] [Related]
13. Stress-induced enhancement of fear conditioning and sensitization facilitates extinction-resistant and habituation-resistant fear behaviors in a novel animal model of posttraumatic stress disorder. Corley MJ; Caruso MJ; Takahashi LK Physiol Behav; 2012 Jan; 105(2):408-16. PubMed ID: 21925525 [TBL] [Abstract][Full Text] [Related]
14. Acoustic startle response in rats predicts inter-individual variation in fear extinction. Russo AS; Parsons RG Neurobiol Learn Mem; 2017 Mar; 139():157-164. PubMed ID: 28131759 [TBL] [Abstract][Full Text] [Related]
15. Effect of combined opioid receptor and α Vo L; Drummond PD J Psychopharmacol; 2017 Jun; 31(6):722-729. PubMed ID: 28168894 [TBL] [Abstract][Full Text] [Related]
16. Effect of recurrent yohimbine on immediate and post-hoc behaviors, stress hormones, and energy homeostatic parameters. Figlewicz DP; Hill SR; Jay JL; West CH; Zavosh AS; Sipols AJ Physiol Behav; 2014 Apr; 129():186-93. PubMed ID: 24565792 [TBL] [Abstract][Full Text] [Related]
17. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial. Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378 [TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats. Park PE; Vendruscolo LF; Schlosburg JE; Edwards S; Schulteis G; Koob GF Int J Neuropsychopharmacol; 2013 Sep; 16(8):1867-75. PubMed ID: 23590881 [TBL] [Abstract][Full Text] [Related]
19. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors. Powell SB; Palomo J; Carasso BS; Bakshi VP; Geyer MA Psychopharmacology (Berl); 2005 Jul; 180(3):491-500. PubMed ID: 15719216 [TBL] [Abstract][Full Text] [Related]
20. A cross species study of heterogeneity in fear extinction learning in relation to FKBP5 variation and expression: Implications for the acute treatment of posttraumatic stress disorder. Galatzer-Levy IR; Andero R; Sawamura T; Jovanovic T; Papini S; Ressler KJ; Norrholm SD Neuropharmacology; 2017 Apr; 116():188-195. PubMed ID: 28025095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]